Literature DB >> 20595498

Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence.

John J Openshaw1, David L Swerdlow, John W Krebs, Robert C Holman, Eric Mandel, Alexis Harvey, Dana Haberling, Robert F Massung, Jennifer H McQuiston.   

Abstract

Rocky Mountain spotted fever (RMSF), a potentially fatal tick-borne infection caused by Rickettsia rickettsii, is considered a notifiable condition in the United States. During 2000 to 2007, the annual reported incidence of RMSF increased from 1.7 to 7 cases per million persons from 2000 to 2007, the highest rate ever recorded. American Indians had a significantly higher incidence than other race groups. Children 5-9 years of age appeared at highest risk for fatal outcome. Enzyme-linked immunosorbent assays became more widely available beginning in 2004 and were used to diagnose 38% of cases during 2005-2007. The proportion of cases classified as confirmed RMSF decreased from 15% in 2000 to 4% in 2007. Concomitantly, case fatality decreased from 2.2% to 0.3%. The decreasing proportion of confirmed cases and cases with fatal outcome suggests that changes in diagnostic and surveillance practices may be influencing the observed increase in reported incidence rates.

Entities:  

Mesh:

Year:  2010        PMID: 20595498      PMCID: PMC2912596          DOI: 10.4269/ajtmh.2010.09-0752

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States.

Authors:  E Hilton; J DeVoti; J L Benach; M L Halluska; D J White; H Paxton; J S Dumler
Journal:  Am J Med       Date:  1999-04       Impact factor: 4.965

2.  Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona.

Authors:  Marina E Eremeeva; Elizabeth A Bosserman; Linda J Demma; Maria L Zambrano; Dianna M Blau; Gregory A Dasch
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

3.  Rocky Mountain spotted fever in the United States, 1997-2002.

Authors:  Alice S Chapman; Staci M Murphy; Linda J Demma; Robert C Holman; Aaron T Curns; Jennifer H McQuiston; John W Krebs; David L Swerdlow
Journal:  Vector Borne Zoonotic Dis       Date:  2006       Impact factor: 2.133

4.  Spatial clustering by disease severity among reported Rocky Mountain spotted fever cases in the United States, 2001-2005.

Authors:  Jennifer Zipser Adjemian; John Krebs; Eric Mandel; Jennifer McQuiston
Journal:  Am J Trop Med Hyg       Date:  2009-01       Impact factor: 2.345

5.  Rocky Mountain spotted fever in the USA: a benign disease or a common diagnostic error?

Authors:  Didier Raoult; Philippe Parola
Journal:  Lancet Infect Dis       Date:  2008-10       Impact factor: 25.071

6.  Doxycycline and staining of permanent teeth.

Authors:  M E Lochary; P B Lockhart; W T Williams
Journal:  Pediatr Infect Dis J       Date:  1998-05       Impact factor: 2.129

7.  The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever.

Authors:  J E Kaplan; L B Schonberger
Journal:  Am J Trop Med Hyg       Date:  1986-07       Impact factor: 2.345

8.  Rickettsialpox in New York City: a persistent urban zoonosis.

Authors:  Christopher D Paddock; Sherif R Zaki; Tamara Koss; Joseph Singleton; John W Sumner; James A Comer; Marina E Eremeeva; Gregory A Dasch; Bryan Cherry; James E Childs
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

9.  Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002.

Authors:  M O'Reilly; C Paddock; B Elchos; J Goddard; J Childs; M Currie
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

10.  Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States.

Authors:  Christopher D Paddock; John W Sumner; James A Comer; Sherif R Zaki; Cynthia S Goldsmith; Jerome Goddard; Susan L F McLellan; Cynthia L Tamminga; Christopher A Ohl
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

View more
  53 in total

1.  Short report: Race and rickettsiae: a United States perspective.

Authors:  F Scott Dahlgren; Ramal Moonesinghe; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

Review 2.  Host, pathogen and treatment-related prognostic factors in rickettsioses.

Authors:  E Botelho-Nevers; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-26       Impact factor: 3.267

Review 3.  Update on tick-borne rickettsioses around the world: a geographic approach.

Authors:  Philippe Parola; Christopher D Paddock; Cristina Socolovschi; Marcelo B Labruna; Oleg Mediannikov; Tahar Kernif; Mohammad Yazid Abdad; John Stenos; Idir Bitam; Pierre-Edouard Fournier; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses.

Authors:  Bin Gong; Thomas Shelite; Fang C Mei; Tuha Ha; Yaohua Hu; Guang Xu; Qing Chang; Maki Wakamiya; Thomas G Ksiazek; Paul J Boor; Donald H Bouyer; Vsevolod L Popov; Ju Chen; David H Walker; Xiaodong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

5.  Rickettsia amblyommatis sp. nov., a spotted fever group Rickettsia associated with multiple species of Amblyomma ticks in North, Central and South America.

Authors:  Sandor E Karpathy; Kimetha S Slater; Cynthia S Goldsmith; William L Nicholson; Christopher D Paddock
Journal:  Int J Syst Evol Microbiol       Date:  2016-09-13       Impact factor: 2.747

6.  Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007.

Authors:  F Scott Dahlgren; Eric J Mandel; John W Krebs; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

7.  Knowledge, attitudes, and practices regarding Rocky Mountain spotted fever among healthcare providers, Tennessee, 2009.

Authors:  Emily Mosites; L Rand Carpenter; Kristina McElroy; Mary J Lancaster; Tue H Ngo; Jennifer McQuiston; Caleb Wiedeman; John R Dunn
Journal:  Am J Trop Med Hyg       Date:  2012-12-12       Impact factor: 2.345

8.  Evaluation of a Spotted Fever Group Rickettsia Public Health Surveillance System in Tennessee.

Authors:  Mary-Margaret A Fill; Abelardo C Moncayo; Karen C Bloch; John R Dunn; William Schaffner; Timothy F Jones
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

9.  Inadequacy of IgM antibody tests for diagnosis of Rocky Mountain Spotted Fever.

Authors:  Jennifer H McQuiston; Caleb Wiedeman; Joseph Singleton; L Rand Carpenter; Kristina McElroy; Emily Mosites; Ida Chung; Cecilia Kato; Kevin Morris; Abelardo C Moncayo; Susan Porter; John Dunn
Journal:  Am J Trop Med Hyg       Date:  2014-08-04       Impact factor: 2.345

10.  Afebrile spotted fever group Rickettsia infection after a bite from a Dermacentor variabilis tick infected with Rickettsia montanensis.

Authors:  Jennifer H McQuiston; Galina Zemtsova; Jamie Perniciaro; Mark Hutson; Joseph Singleton; William L Nicholson; Michael L Levin
Journal:  Vector Borne Zoonotic Dis       Date:  2012-11-15       Impact factor: 2.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.